Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Maternal serum screening

J C Carroll1

  • 1Department of Family and Community Medicine, University of Toronto.

Canadian Family Physician Medecin De Famille Canadien
|October 1, 1994
PubMed
Summary
This summary is machine-generated.

Maternal serum screening (MSS) identifies risks for fetal Down syndrome and neural tube defects using three markers. This protocol guides the investigation of positive results, emphasizing physician education for better patient counseling.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multigene expression profile testing in breast cancer: is there a role for family physicians?

Current oncology (Toronto, Ont.)·2017
Same author

Efficacy of an educational intervention on family physicians' risk assessment and management of colorectal cancer.

Journal of community genetics·2014
Same author

Public attitudes towards genomic risk profiling as a component of routine population screening.

Genome·2013
Same author

Family history: impact on coronary heart disease risk assessment beyond guideline-defined factors.

Public health genomics·2013
Same author

Family history tools in primary care: does one size fit all?

Public health genomics·2012
Same author

The challenge of teaching obstetrics to family practice residents.

Canadian family physician Medecin de famille canadien·2011
Same journal

Impact of virtual case conferences between primary care clinicians and an interdisciplinary chronic pain clinic.

Canadian family physician Medecin de famille canadien·2026
Same journal

Canadian family physician Medecin de famille canadien·2026
Same journal

Predictors of high-performing family medicine clinics: Prospective cohort study in Alberta.

Canadian family physician Medecin de famille canadien·2026
Same journal

Acetylsalicylic acid use for artial fibrillation and bleeding risk.

Canadian family physician Medecin de famille canadien·2026
Same journal

Clinical practice guidelines: Important tools to teach the art of medicine.

Canadian family physician Medecin de famille canadien·2026
Same journal

Paratonia in advanced dementia: Challenges and evidence-based interventions.

Canadian family physician Medecin de famille canadien·2026
See all related articles

Area of Science:

  • Obstetrics and Gynecology
  • Prenatal Diagnostics
  • Medical Genetics

Background:

  • Maternal serum screening (MSS) is a key prenatal diagnostic tool.
  • It assesses risk for fetal chromosomal abnormalities like Down syndrome and open neural tube defects.
  • Positive MSS results occur in approximately 8% of pregnancies, necessitating further investigation.

Purpose of the Study:

  • To present a standardized protocol for investigating positive maternal serum screening results.
  • To ensure appropriate follow-up for women with elevated risk indicated by MSS.
  • To highlight the importance of family physician awareness and patient guidance regarding MSS.

Main Methods:

  • The study outlines a protocol for the systematic investigation of women with positive MSS results.

Related Experiment Videos

  • This involves understanding the implications of the three primary serum markers: alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.
  • The protocol emphasizes clear communication and guidance pathways.

    • Main Results:

    • A protocol for investigating positive MSS results is detailed.
    • The protocol aims to manage the 8% of women who initially receive positive screening results.
    • Effective investigation protocols are crucial for accurate risk assessment and patient management.

    Conclusions:

    • A structured approach to investigating positive maternal serum screening is essential.
    • Informing family physicians about MSS protocols is critical for patient care.
    • Enhanced physician knowledge facilitates better patient counseling and management of prenatal risks.